CoChat

Effectiveness of internet-based management in newly diagnosed young adults with type 2 diabetes: a prospective comparative study

Open access
Li, Zhi, Luo, Dahang, Li, Zhongjin · 2025 · Endocrine Connections

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index; none of the 7 sources its claims cite is checked for support yet.

Abstract

Background: The incidence of type 2 diabetes mellitus (T2DM) is rising among young adults, posing challenges for long-term management after discharge. Methods: This prospective comparative study included 120 newly diagnosed young adults with T2DM admitted between January and December 2023. Participants were randomized into intervention or control groups (n = 60 each). All patients received standard diabetes education and short-term insulin pump intensive therapy during hospitalization. After discharge, the control group received traditional care, while the intervention group utilized an internet-based management system incorporating continuous glucose monitoring, personalized feedback and remote healthcare team consultations. Primary outcomes included HbA1c, fasting blood glucose (FBG), insulin resistance (HOMA-IR) and β-cell function (HOMA-β and fasting C-peptide). Secondary outcomes included lipid profiles, renal function (urine albumin/creatinine ratio (UACR)), blood pressure, quality of life (SF-36) and depression scores (PHQ-9). Results: At 12 months, the intervention group had significantly lower HbA1c (6.5 vs 7.2%, P < 0.001) and better improvements in FBG, HOMA-IR, HOMA-β, fasting C-peptide, triglycerides and low-density lipoprotein cholesterol (P < 0.01). Improvements in UACR and blood pressure were minimal (P > 0.05). SF-36 and PHQ-9 scores improved more significantly in the intervention group (P < 0.01). Diabetes remission rates were higher in the intervention group (60 vs 37%, P = 0.028) and remained significant after adjusting for baseline variables (P = 0.015). Conclusion: The internet-based management system with personalized feedback significantly improved glycemic control and quality of life in young adults with T2DM.

Overview

CoChat Summary

TL;DR

In 120 newly diagnosed young adults with type 2 diabetes, an internet-based management system with continuous glucose monitoring and personalized feedback improved glycemic control and quality of life compared with traditional care over 12 months. Diabetes remission was higher in the intervention group (60% vs 37%).

Key findings

  • At 12 months, the intervention group had lower HbA1c (6.5 vs 7.2%, P < 0.001) and greater improvements in FBG, HOMA-IR, HOMA-β, fasting C-peptide, triglycerides and LDL-C (P < 0.01); average HbA1c decrease was −1.8% vs −1.2%.
  • Diabetes remission occurred in 36/60 (60%) intervention patients vs 22/60 (37%) control patients; the abstract reports P = 0.028, Table 3 reports P = 0.018, and the text reports P = 0.015. Adjusted logistic regression ORs were 0.58 (95% CI 0.35–0.95, P = 0.028), 0.65 (0.42–0.88, P = 0.015) and 0.68 (0.45–0.91, P = 0.012) across models.
  • SF-36 scores improved from 65.2 ± 1.33 to 78.4 ± 1.17 in the intervention group vs 64.7 ± 1.42 to 70.5 ± 1.39 in controls (between-group P < 0.01); PHQ-9 scores decreased from 8.4 ± 0.54 to 5.3 ± 0.48 vs 8.2 ± 0.53 to 6.9 ± 0.52 (between-group P < 0.05).
  • UACR and blood pressure improvements were minimal and not statistically significant (P > 0.05). Hypoglycemia OR was 0.65 (95% CI 0.43–0.98, P = 0.035) and hyperglycemia OR was 0.75 (95% CI 0.50–1.10, P = 0.045).

Methods

  • Prospective comparative study at one endocrinology department from January to December 2023; 120 newly diagnosed T2DM patients aged 18–40 were randomized 1:1 to intervention or control (n = 60 each).
  • All patients received standard diabetes education and 7-day insulin pump intensive therapy during hospitalization. After discharge, controls received traditional care, while the intervention group used an internet-based system with continuous glucose monitoring, personalized dietary/exercise feedback and remote healthcare team consultations; average interactions over 12 months were 65 vs 22.
  • Outcomes included HbA1c, FBG, HOMA-IR, HOMA-β, fasting C-peptide, lipids, UACR, blood pressure, SF-36, PHQ-9 and diabetes remission. Analyses used t-tests, Mann–Whitney U tests, χ² tests, repeated measures ANOVA and multivariate logistic regression in SPSS, R and Python.

Limitations

  • The paper states: relatively small sample size, single-center design, 12-month follow-up insufficient for long-term effects, and additional costs of continuous glucose monitoring devices, platform maintenance and remote support may limit adoption in low-resource settings.
  • Evident from the text: randomization is described but blinding is not reported; medication adherence was verified partly through self-reported logs; remission P-values are inconsistent across the abstract, Table 3 and text; and the reported hyperglycemia OR confidence interval includes 1 despite P = 0.045.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1530/ec-24-0576

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Changes in glycemic, metabolic, renal and cardiovascular parameters over time. Dynamic changes in key clinical parameters, including glycemic control, lipid profiles, renal function and blood pressure, are shown for the intervention and control groups over the 12-month follow-up period. Data are presented as the means ± SEM, and statistical significance for group differences at each time point is denoted by *P < 0.05 and **P < 0.01, as determined by repeated measures ANOVA. (A) HbA1c, glycated hemoglobin; (B) TC, total cholesterol; (C) fasting C-peptide levels with adjusted significance positions; (D) FBG, fasting blood glucose; (E) TG, triglycerides; (F) UACR, urinary albumin-to-creatinine ratio; (G) HOMA-IR, homeostasis model assessment of insulin resistance; (H) LDL-C, low-density lipoprotein cholesterol; (I) SBP, systolic blood pressure; (J) HOMA-β, homeostasis model assessment of β-cell function; (K) HDL-C, high-density lipoprotein cholesterol; (L) DBP, diastolic blood pressure.
Figure 1 Changes in glycemic, metabolic, renal and cardiovascular parameters over time. Dynamic changes in key clinical parameters, including glycemic control, lipid profiles, renal function and blood pressure, are shown for the intervention and control groups over the 12-month follow-up period. Data are presented as the means ± SEM, and statistical significance for group differences at each time point is denoted by *P < 0.05 and **P < 0.01, as determined by repeated measures ANOVA. (A) HbA1c, glycated hemoglobin; (B) TC, total cholesterol; (C) fasting C-peptide levels with adjusted significance positions; (D) FBG, fasting blood glucose; (E) TG, triglycerides; (F) UACR, urinary albumin-to-creatinine ratio; (G) HOMA-IR, homeostasis model assessment of insulin resistance; (H) LDL-C, low-density lipoprotein cholesterol; (I) SBP, systolic blood pressure; (J) HOMA-β, homeostasis model assessment of β-cell function; (K) HDL-C, high-density lipoprotein cholesterol; (L) DBP, diastolic blood pressure.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 5 Not checked · 24 Own results and interpretations

10 more claims

Create a free account to see all 29 claims and to verify the 7 references still open.

See all claims — free account
  • It may state two separate claims as one. 6
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 8

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Research works printed but not linked: 3

  1. Mannucci, 2014, Adherence to chronic antihyperglycaemic treatment in the elderly: a retrospective cohort study, J Clin Endocrinol Metab, 99, 1077
  2. Lipscombe, 2016, Impact of diabetes on cardiovascular disease in women and men: a comparison of incidence and outcomes, Diabetologia, 58, 543
  3. Han, 2016, Complications of type 2 diabetes mellitus in newly diagnosed type 2 diabetes patients, Diabetes Metab J, 40, 314

Cited by

See all 6

Metadata

Authors
Li, Z., Luo, D., & Li, Z.
Affiliations
The Affiliated Shunde Hospital of Jinan University (CN)
Corresponding author
Li, Zhi
Venue
Endocrine Connections
Published
2025-02-12
Volume
14
Issue
4
Pages
e240576
ISSN
2049-3614 (ISSN-L)
OpenAlex
W4407409049
Cited by
6
References
24
Citations by year
2026: 4 · 2025: 2
FWCI
2.59
Type
journal article
Language
en
Open access
Locations
  • Endocrine Connections (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Keywords
type 2 diabetes, young adults, continuous glucose monitoring, personalized feedback, remote care, diabetes remission, glycemic control, insulin resistance, beta-cell function, quality of life, depression, lipid profile, albuminuria, insulin pump therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-20, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-20 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.